IL81395A0 - Novel derivatives of erythromycylamine - Google Patents

Novel derivatives of erythromycylamine

Info

Publication number
IL81395A0
IL81395A0 IL81395A IL8139587A IL81395A0 IL 81395 A0 IL81395 A0 IL 81395A0 IL 81395 A IL81395 A IL 81395A IL 8139587 A IL8139587 A IL 8139587A IL 81395 A0 IL81395 A0 IL 81395A0
Authority
IL
Israel
Prior art keywords
erythromycylamine
novel derivatives
nucleus
chem
new
Prior art date
Application number
IL81395A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL81395A0 publication Critical patent/IL81395A0/xx
Priority to IL91798A priority Critical patent/IL91798A0/xx
Priority to IL91799A priority patent/IL91799A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mattresses And Other Support Structures For Chairs And Beds (AREA)
  • Laminated Bodies (AREA)
  • Springs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL81395A 1986-02-03 1987-01-27 Novel derivatives of erythromycylamine IL81395A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL91798A IL91798A0 (en) 1986-02-03 1989-09-27 Novel derivatives of erythromycylamine
IL91799A IL91799A0 (en) 1986-02-03 1989-09-27 Novel derivatives of erythromycylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82491186A 1986-02-03 1986-02-03

Publications (1)

Publication Number Publication Date
IL81395A0 true IL81395A0 (en) 1987-08-31

Family

ID=25242621

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81395A IL81395A0 (en) 1986-02-03 1987-01-27 Novel derivatives of erythromycylamine

Country Status (16)

Country Link
EP (1) EP0238178B1 (ja)
JP (1) JPS62185094A (ja)
KR (1) KR890003844B1 (ja)
CN (1) CN87100536A (ja)
AT (1) ATE54151T1 (ja)
AU (1) AU584270B2 (ja)
CA (1) CA1265131C (ja)
DE (1) DE3763413D1 (ja)
DK (1) DK49487A (ja)
ES (1) ES2055699T3 (ja)
GR (1) GR3000647T3 (ja)
HU (2) HU197023B (ja)
IL (1) IL81395A0 (ja)
NZ (1) NZ219083A (ja)
PT (1) PT84205B (ja)
ZA (1) ZA87591B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729369D0 (en) * 1987-12-16 1988-01-27 Beecham Group Plc Chemical compounds
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
US20020132782A1 (en) * 2001-01-18 2002-09-19 Zhenkun Ma 9-amino erythromycin derivatives with antibacterial activity
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) * 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
GB1341022A (en) * 1970-04-13 1973-12-19 Lilly Industries Ltd Erythromycylamine compounds
US3681322A (en) * 1970-04-13 1972-08-01 Lilly Co Eli Adducts of aliphatic and araliphatic aldehydes and erythromycylamine or erythromycyl b amine
GB1345524A (en) * 1970-09-30 1974-01-30 Lilly Industries Ltd N-heteroarylidene erythomycylamines
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf

Also Published As

Publication number Publication date
HUT43086A (en) 1987-09-28
ATE54151T1 (de) 1990-07-15
CA1265131A (en) 1990-01-30
ZA87591B (en) 1988-09-28
HU197023B (en) 1989-02-28
EP0238178B1 (en) 1990-06-27
HU201561B (en) 1990-11-28
EP0238178A1 (en) 1987-09-23
PT84205B (pt) 1989-09-14
AU584270B2 (en) 1989-05-18
JPS62185094A (ja) 1987-08-13
HUT50608A (en) 1990-03-28
KR890003844B1 (ko) 1989-10-05
ES2055699T3 (es) 1994-09-01
DK49487A (da) 1987-08-04
CN87100536A (zh) 1987-08-19
NZ219083A (en) 1989-08-29
GR3000647T3 (en) 1991-09-27
CA1265131C (en) 1990-01-30
AU6818787A (en) 1987-08-06
PT84205A (en) 1987-02-01
DK49487D0 (da) 1987-01-30
KR870007925A (ko) 1987-09-22
DE3763413D1 (en) 1990-08-02

Similar Documents

Publication Publication Date Title
IN170909B (ja)
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
DE3779053D1 (ja)
GR3004139T3 (ja)
AU6853187A (en) 1,4-benzoxazine derivatives
FI863523A (fi) Foerfarande foer framstaellning av icke-toxiska salter av 6-metyl-3,4-dihydro-1,2,3-oxatiazin-4-on-2,2 -dioxider.
DE3763413D1 (en) Erythromycylamin-derivate.
EP0274064A3 (en) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene pgi2 derivatives
DE3475073D1 (en) Azahomoerythromycin b derivatives and intermediates thereof
EP0175266A3 (en) Antihypertensive derivatives
AU6646586A (en) 1,4-disubstituted 1-azolyl-3,3-dimethylbutan-2-one and -ol derivatives
EP0612750A3 (en) Cephalosporinderivatives.
DE3686632D1 (de) Antibiotische derivate, ihre herstellung und verwendung.
FR2597105B1 (fr) Derives antibiotiques de la famille des 20-0-acyl-19,20-enolmacrolides
PT85645A (en) 2-(1-oxo-1-imino-1-thiacylcloalkyl)-thiopenem derivatives
EP0247595A3 (en) New azaphospholones and use thereof
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
ATE80163T1 (de) Antibiotische derivate, ihre herstellung und verwendung.
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
IT8421467A1 (it) Nuovo derivato cefalosporinico somministrabile per via orale